While valuable for hazard identification,
in vitro genotoxicity tests that are conducted in 2D monolayer cell cultures possess limitations to accurately envisage
in vivo outcomes and may result in unnecessary follow-up
in vivo studies. One limitation is their relevance to actual human exposure and the assessment of genotoxicity in tissues representative of “sites-of-first-contact” with genotoxic agents. The revised OECD testing guidelines had emphasized the need for considering site-of-first-contact effect when carrying out genotoxic hazard investigations. To date, only
in vivo studies can adequately address the oral/gastrointestinal route of exposure and there exists no validated
in vitro assay for ingestible substances. Previously, we described the development of a new human Reconstructed Intestine Micronuclei Cytome (RICyt) assay using
EpiIntestinal™ microtissues for site-of-contact genotoxic hazard identification of orally ingested materials. The human small intestine is where approximately 90 % of the digestion and adsorption of food occurs and a major exposure site of ingested genotoxicants, thus a key site for evaluation. Here, we have investigated on the qualification of the RICyt assay in genotoxic hazard identification. The assay platform was challenged with a training set of 16 test materials which include standard reference genotoxins, non-genotoxins and food relevant substances with various mode of actions. The overall RICyt accuracy was 93.3 % with sensitivity of 83.3 % and specificity of 100 %. Majority of the test materials were correctly identified though yielded one false negative (KBrO
3) and one equivocal outcome (EUG). MCT, a known genotoxin, with no known effect on the GI tract, did not induce significant MN, showcasing the ability of the assay to detect tissue specific genotoxicity. These results emphasize that the RICyt assay is promising
in vitro tool for genotoxic hazard identification of orally ingested substances.
